Skip to main content
. 2023 Jul 11;14:1178489. doi: 10.3389/fphar.2023.1178489

FIGURE 1.

FIGURE 1

Experimental design and establishment of drug resistant cell lines. (A). Schematic description of the experimental set-up for barcoding of Caco-2 and HT-29 cell lines alongside with drug treatment schedules. (B). MTT cell viability assay results for capecitabine treatment in Caco-2 cell line. (C). Dose response curve analysis of irinotecan treatment in HT-29 cell line based on MTT cell viability assay. (D). MTT cell viability results of dose response analysis for capecitabine-resistant lines and (E). irinotecan-resistant lines versus barcoded DMSO, initial and non-barcoded parental cell lines. Error bars represent SEM.